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The life-course impact of smoking 
on hypertension, myocardial 
infarction and respiratory diseases
Kaiye Gao1,2, Xin Shi3 & Wenbin Wang1
The objective of this study was to examine the impact of smoking on respiratory diseases, hypertension 
and myocardial infarction, with a particular focus from a life-course perspective. In this study, 
28,577 males from a Chinese longitudinal survey were analysed. The effects of smoking on the risk 
of respiratory diseases, hypertension and myocardial infarction were assessed from a life-course 
perspective and a current view separately. No significant associations were found between smoking and 
the risk of incident respiratory diseases, hypertension and myocardial infarction in the group younger 
than 35. Among study participants aged between 36–55 and 56–80, smoking was positively associated 
with the risk of incident respiratory diseases, hypertension and myocardial infarction from the life-
course perspective, and the risk increased with age. In contrast, the results from a current view showed 
inverse associations between smoking and the risk of the diseases mentioned above. Our findings 
highlight that it is essential to quantify the effects of smoking from a life-course perspective in future 
research and to suggest that smokers quit smoking as soon as possible, regardless of the temporary side 
effects of quitting.
Smoking can affect the risk of incident hypertension1, 2 and myocardial infarction3, 4. As chronic diseases, 
smoking-caused hypertension and myocardial infarction can not only reduce life expectancy5, 6 but also detri-
mentally affect quality of life7, 8. We should note that tobacco smoking is also one of the main preventable causes 
of hypertension and myocardial infarction9, 10, which means that these diseases could be controlled to a large 
extent by smoking cessation. Abundant evidence has proven that cigarette smoking is associated with some symp-
toms of the respiratory system11, 12.
Although smoking has been identified as a health risk factor, some studies documented opposite findings 
in terms of hypertension and myocardial infarction. For instance, some researchers have reported lower blood 
pressure levels among smokers compared to former smokers13 and increases in blood pressure after smoking 
cessation14, 15. The results from a male steel workers’ follow-up have revealed that the rate of hypertension among 
continuous smokers is lower than never-smokers and ex-smokers16. Smoking has also been primarily associated 
with a decreased risk of pregnancy-induced hypertension among growth-restricted babies17. As a result, it is still 
unclear to what extent cigarette smoking is a risk factor for the development of hypertension18. Similar phenom-
ena were found for myocardial infarction. One study found that those patients who quit smoking after myocardial 
infarction generally had a somewhat more severe clinical course than those who continued to smoke19. Moreover, 
related studies suggested that there is no significant dose-response relationship between smoking and the risk of 
hypertension and myocardial infarction20, 21.
In the studies mentioned above, most only used current smoking behaviour (status classification: 
non-smokers, current smokers and former smokers; cigarette consumption classification: light smokers, heavy 
smokers and so on) to analyse the effects of smoking on health. For instance, Green13 and Okubo20 classified 
smokers by current smoking status and number of cigarettes smoked per day in their study, while Peltier17 only 
used the data for smoking in a specific period. This may lead to a biased evaluation of the effects of smoking. 
There are several possible causes accounting for this problem. First, smoking generally has a long-term, cumula-
tive effect on health, so current smoking may not damage health immediately and smokers recover slowly from 
the damage caused by smoking22–25. Specifically, the initiation of chronic diseases is also an agonizingly slow 
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process, so current smoking cannot be a direct indicator of these diseases. Second, smoking can produce a tem-
porary excitement leading to an optimistic self-estimation of health status, and continual smoking can further 
mask the early warning symptoms of some diseases26. Last, since smokers may change their smoking habit at 
times, current smoking status or cigarette consumption may not effectively reflect tobacco intake27, 28. Given the 
current evidence and research, the impact of smoking on health, particularly on chronic diseases, may be delayed, 
and thus, current smoking status or consumption may not be closely correlated with the current health status.
Quitting smoking is usually associated with either increased concern regarding health or willingness to 
improve health status29. However, the contradictory effects of current smoking consumption on hypertension 
and myocardial infarction, as well as the insignificant dose-response relationship between them, have become 
strong resistances for those smokers who want to quit smoking. Therefore, it remains critical to study the effects 
of smoking on hypertension and myocardial infarction using information from a life-course perspective, instead 
of current smoking status or consumption30. Herein, from Chinese longitudinal survey data, we proposed a new 
variable that can reflect smoking consumption over a life-course range. We first examined the effects of smoking 
on hypertension and myocardial infarction using the life-course-adjusted number of cigarettes smoked per day 
(LCS) and the current numbers of cigarettes smoked per day (CCS) separately and compared the results. Second, 
similar analyses were also conducted for respiratory diseases as a comparison, due to their close relationship with 
smoking11, 12. Finally, some reasonable explanations about the impact of smoking on respiratory diseases, hyper-
tension and myocardial infarction are discussed separately, which can help people to enhance their awareness of 
quitting smoking and inform them of the specific hazards of smoking, rather than a fuzzy sense of ‘smoking is 
harmful to health’.
Results
Sample population characteristics. As noted, Table 1 illustrates the descriptive characteristics of the pop-
ulation sample, including the number, percentage, and CCS and LCS in different groups classified by age, BMI, 
educational attainment, occupation types and region. In addition, the patients with respiratory diseases, hyper-
tension, and myocardial infarction among the study samples are also shown in Table 1. Notably, the average CCS 
Variable Number Per cent % CCS p Value LCS p Value
All samples 28577 100 9.46 — 5.77 —
Age
 18~35 8120 28.41 8.15 — 3.20 —
 36~55 12362 43.26 11.46 — 7.10 —
 56~80 8095 28.33 8.06 <0.01 6.45 <0.01
BMI
 Normal 20354 71.23 9.89 — 5.87 —
 Over weight 6630 23.20 8.58 — 5.67 —
 Obese 1593 5.57 7.68 <0.01 4.94 <0.01
Educational attainment
 Primary or less 11019 38.56 10.07 — 6.60 —
 Middle 14267 49.92 9.57 — 5.50 —
 College 3291 11.52 4.18 <0.01 6.96 <0.01
Occupation types
 Unemployed 6408 22.42 6.87 — 5.56 —
 White collar 3933 13.76 8.93 — 5.09 —
 Light physical 4536 15.87 9.72 — 5.73 —
 Hard physical 13700 47.94 10.75 <0.01 6.08 <0.01
Region
 East 9430 33.00 8.49 — 5.06 —
 Middle 11894 41.62 9.96 — 6.04 —
 West 7253 25.38 9.89 <0.01 6.26 <0.01
Drinking behaviour
 Non-drinkers 12857 44.99 7.05 — 4.43 —
 Barely 3106 10.87 9.31 — 5.20 —
 Less frequently 4442 15.54 10.29 — 5.92 —
 Frequently 8172 28.60 12.87 <0.01 8.03 <0.01
Diseases
 Respiratory 621 2.17 8.38 0.02 7.14 <0.01
 Hypertension 2069 7.24 7.05 <0.01 6.06 0.05
 Myocardial Infarction 227 0.79 5.56 <0.01 5.28 0.40
Table 1. Descriptive Statistics of Sample. The p Values came from F tests between subgroups.
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was larger than the average LCS in most subgroups, and significant differences in CCS and LCS were observed in 
almost all subgroups.
Impact of CCS and LCS. We categorised our study samples into three analysis groups based on age (under 
35, 36–55, and 56–80 years old). The results in Table 2 show that among participants less than 35 years of age, no 
significant (p < 1) association was found between the CCS or LCS and the risk of any disease. However, a noticea-
ble fact was that the significance for CCS (0.1846, 0.1731 and 0.451) in the three age groups was generally stronger 
than for LCS (0.9105, 0.5984 and 0.7067).
Table 3 illustrates the results for the participants aged between 36 and 55. In this group, the correlations 
between LCS and the risk of these three diseases were significant. The OR of respiratory diseases caused by 
increased LCS was 1.1057 (95% CI: 0.9861, 1.2407, p: 0.0863), while the data for CCS were not significant (p: 
0.6386). The LCS had a significant negative correlation with the risk of incident hypertension (OR 0.1.0754, 95% 
CI 1.0050 to 1.1503) and myocardial infarction (OR 1.2952, 95% CI 1.0202 to 1.6445), whereas CCS was signifi-
cantly associated with increased risk for these three diseases (OR 0.8800, 95% CI 0.8079 to 0.9578 and OR 0.7916, 
95% CI 0.6484 to 0.9965).
The ORs for the participants aged between 56 and 80 are provided in Table 4. CCS was negatively associated 
with the risk of developing respiratory diseases, hypertension and myocardial infarction (OR 0.8720, 0.9312, 
0.7428). In contrast, the increase in LCS was a significant risk factor for respiratory diseases (OR 1.1245, 95% CI 
1.0212 to 1.2370), hypertension (OR 1.1046, 95% CI 1.0161 to 1.2012) and myocardial infarction (OR 1.4202, 
95% 1.0356 to 1.8048).
The OR trends. The LCS-related risk of incident respiratory diseases, hypertension and myocardial infarc-
tion increased with age (Tables 2–4). In contrast, CCS showed unclear trends in the risk for these diseases. The 
ORs for myocardial infarction decreased with age, while respiratory diseases and hypertension showed no sig-
nificant trend. It was also noticeable that compared with the other two groups, the group aged between 56 and 80 
years old had more significant outcomes (Table 4).
Discussion
In this comparative prospective cohort study, we found that the increase in LCS resulted in a significantly 
increased risk of developing respiratory diseases, hypertension and myocardial infarction. Initially, the magnitude 
of this effect may be modest, but it increases with age. This was mainly because the incidences of these diseases 
and the accumulative effect of smoking increase with age31. In addition, the number of significant outcomes in 
Term
CCS LCS
N OR CI p Value OR CI p Value
Respiratory Diseases 120 0.8571 0.6831–1.0765 0.1846 1.0141 0.7965–1.2914 0.9105
Hypertension 52 1.2238 0.9154–1.6367 0.1731 1.0304 0.7543–1.4065 0.8503
Myocardial Infarction 4 0.8485 0.5531–1.3015 0.4515 0.9191 0.5912–1.4284 0.7067
Table 2. Statistics for average number of cigarettes smoked per day for those aged under 35 years. The unit of 
CCS and LCS is 10 cigarettes per day.
Term
CCS LCS
N OR CI p Value OR CI p Value
Respiratory Diseases 250 0.9714 0.8597–1.0970 0.6386 1.1057’ 0.9861–1.2407 0.0863
Hypertension 592 0.8800* 0.8079–0.9578 0.0032 1.0754* 1.0050–1.1503 0.0359
Myocardial Infarction 123 0.7916* 0.6484–0.9665 0.0217 1.2952* 1.0202–1.6445 0.0336
Table 3. Statistics for average number of cigarettes smoked per day for those aged between 36 and 55 years. 
‘*’Indicates p < 0.05. Results that approach significance are indicated with the symbol ‘”. The unit of CCS and 
LCS is 10 cigarettes per day.
Term
CCS LCS
N OR CI p Value OR CI p Value
Respiratory Diseases 252 0.8720* 0.7621–0.9980 0.0471 1.1245* 1.0212–1.2370 0.0167
Hypertension 1425 0.9312* 0.8711–0.9960 0.0371 1.1046* 1.0161–1.2012 0.0197
Myocardial Infarction 100 0.7428* 0.5777–0.9549 0.0202 1.4202* 1.0356–1.8048 0.0165
Table 4. Statistics for average number of cigarettes smoked per day for those aged between 56 and 80 years. 
‘*’Indicates p < 0.05. Results that approach significance are indicated with the symbol ‘”. The unit of CCS and 
LCS is 10 cigarettes per day.
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the elderly group was higher than in the young group. Among the participants aged between 56 and 80 years, all 
of the risks of developing these diseases were found to be significantly associated with CCS, while none of the 
outcomes were significant among the participants who were under the age of 35. This was probably due to the low 
incidence of these diseases among young adults.
Although cigarette smoking has many well-established detrimental health effects, there is a debate about the 
variable effects of smoking on hypertension and myocardial infarction. In particular, smoking cessation decreases 
inflammation but may bring weight gain2, 32–35. Clinical and animal studies have confirmed a strong relationship 
between obesity and hypertension36. Accumulating evidence points to visceral obesity as the most important risk 
factor for hypertension and cardiovascular disease37. In particular, weight gain could cause higher blood pressure, 
heart rate, and hyperlipidaemia16, 38. These may increase the risk of developing hypertension and further lead to a 
higher risk of myocardial infarction14, 38–40. This is consistent with our finding that CCS was inversely associated 
with the risk of hypertension and myocardial infarction. However, the increase in LCS was associated with higher 
risks of hypertension and myocardial infarction in our study. This is also consistent with previous research finding 
that cigarette intake is closely associated with a higher risk of hypertension and myocardial infarction long-term1–3.
Similar outcomes were observed in the results for respiratory diseases. However, the explanation for the results 
of respiratory diseases was different by respiratory disease. There are some subtypes of respiratory diseases that 
are not chronic diseases, such as acute upper respiratory infection, and these non-chronic respiratory diseases can 
be cured easily short-term. On the other hand, patients with respiratory diseases usually have a greater and more 
urgent need to stop smoking than the average smoker12. Thus, regarding respiratory diseases, the effects of current 
smoking status or dose may become unstable due to the fact that many smokers just quit smoking for a short term 
for curing non-chronic diseases, whereas ex-smokers are usually those with serious chronic diseases. Our results 
also revealed the variable effects of CCS on the risk of respiratory diseases. However, smoking has long been 
suggested to damage the respiratory tract41. With age, the risk of respiratory diseases becomes increasingly higher 
among smokers, and many of them have chronic respiratory diseases that are hard to cure. This was also shown in 
our study, where increases in LCS are associated with a higher risk of respiratory diseases.
LCS reflected the real smoking status and dose more effectively and reasonably than CCS. We observed that LCS 
had more significant outcomes than CCS in the elderly. We also found that LCS was associated with an elevated risk, 
while CCS was generally related to a reduced risk. Moreover, the LCS showed an increasing trend with age groups, 
whereas the data for CCS illustrated an unclear trend. In addition, the comparison between CCS and LCS gave 
some valid explanations as to why some studies found that smoking can positively affect human health in terms of 
respiratory diseases, hypertension and myocardial infarction. To our knowledge, this is the first time a continuous 
variable from a life-course perspective was used to quantify the impact of smoking on risks of respiratory diseases, 
hypertension and myocardial infarction, and we proved that this is more reasonable than only from a current view.
An important limitation of our study was the limited waves of our surveyed samples (average approximately 
3.5 per person). This may lead to a biased estimation of the LCS and further cause a deviation in the outcomes. 
Another limitation was that our study mainly focused on respiratory diseases, hypertension and myocardial 
infarction. We did not elucidate the relation between this new smoking indicator variable with other outcomes 
(e.g., cancers) due to the lack of data. Thus, such assessments would need more research.
In conclusion, our study suggested that life-course-adjusted smoking consumption is significantly positively 
associated with risks of incident respiratory diseases, hypertension and myocardial infarction, and these risks 
will further increase with age. In contrast, the effect of current smoking consumption is unclear. Our analyses 
also gave some reasonable explanations of the insignificance of the “dose-relationship” and the phenomenon of 
“positive effects”. Concerns should be raised that smoking can damage health over the long-term, although the 
effects may not appear immediately or at a young age. Temporary clinical symptoms caused by smoking cessa-
tion cannot be a resistance for smokers who are trying to quit smoking. Furthermore, it is important that future 
research about the relationship between smoking and health should be conducted from a life-course perspective.
Methods
Study design and population. We used data from the Chinese Health and Nutrition Survey (CHNS), a 
longitudinal survey conducted by the Carolina Population Centre at the University of North Carolina at Chapel 
Hill, USA, and the National Institute of Nutrition and Food Safety at the Chinese Centre for Disease Control 
and Prevention. CHNS used a multistage random cluster method to draw samples from nine provinces that var-
ied substantially in geography, economic development, public resources, and health indicators42. A standardized 
questionnaire was used to collect detailed information for demographic and socioeconomic background, health, 
and nutrition from households and their members. It also includes collected information on community services 
and infrastructure from a knowledgeable community resident.
There are 19,000 participants from approximately 4400 households in the CHNS. The study was conducted in 1989, 
and there were eight survey follow-up waves between 1991 and 2011. For our study, we excluded the 1989 wave because 
it did not collect information about the smoking behaviour of the respondents. From 1991 onwards, each wave of the 
survey asked whether the respondent had ever smoked a cigarette or a pipe and how many cigarettes had been smoked 
per day recently. Due to the difficulty of assigning an underlying disease from clinical symptoms in ageing people, all 
analyses were restricted to diseases occurring at ages 18–79, with censoring when men reached 80 years old (or moved 
away from study areas). Females were not included in our study due to a low rate of smoking43. Excluding participants 
who had invalid, error and incomplete cases on smoking variables, the sample size for the analyses was 28,577.
Ethical statement. Ethics permission was obtained from the Institute for Nutrition and Food Safety, the 
China Center for Disease Control (China CDC). All participants were fully informed of the purpose of the study 
and invited to participate voluntarily. Written consent letters were also obtained from each participant. Methods 
were carried out in accordance with the approved guidelines.
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Independent variables. There are two independent variables in our analysis. The first one is the current 
number of cigarettes smoked per day (CCS). This variable was directly collected from the questionnaire. We 
assigned a value of “0” to CCS for never smokers and ex-smokers. The other variable is the life-course-adjusted 
number of cigarettes smoked per day (LCS), which was derived from the CHNS data. The LCS was calculated by 
dividing the total number of cigarettes smoked (until the participant was surveyed) by the survival time from 
birth (day); see Equation (1). In other words, LCS is the average number of cigarettes smoked per day from the 
life-course perspective.
=
− × × + ∑ − × + × ×= − −LCS
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r s r k r
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LCSn       LCS at the nth survey
tn           Age of the first survey (the rth survey in total) that participant started to report a smoking status.
ts           Age of starting smoking
tk           Age of the kth survey after the participant started to report a smoking status.
Cr         Current number of cigarettes smoked per day at the rth survey that participant started to report a smok-
ing status.
Ck         Current number of cigarettes smoked per day at the kth survey that participant started to report a 
smoking status.
I           Indicator of whether in a smoking status (0 if the participant has quit smoking)
Both independent variables were treated as continuous variables. To our best knowledge, self-reported smok-
ing behaviour can be used to measure smoking consumption in subsequent population-based studies44, 45.
Dependent variables. We extracted three (respiratory diseases, hypertension and myocardial infarction) 
different disease diagnosis outcomes (occurred or not) from the CHNS questionnaire as dependent variables. The 
respiratory diseases outcome of respondents was obtained from the question, “What was the doctor’s diagnosis 
of your illness or injury?” and one of the choices, “respiratory disease”. Diagnosis outcomes for hypertension and 
myocardial infarction were collected at the session of the disease history in the questionnaire. All dependent 
variables are binary, where “1” represents suffering from this disease and “0” otherwise.
Covariates. The analyses were adjusted for three groups of covariates. The first group described biological 
characteristics, including age and body mass index (BMI). Age was included because it is closely correlated with 
both smoking status and health status. Similarly, BMI was covered because the relationship between smoking and 
these diseases may be affected by body weight. In this study, we treated age as a continuous variable and stratified 
our samples by baseline BMI using World Health Organization criteria (normal: <24 kg/m2, over-weight: 18.5 to 
<25 kg/m2, and obese: >=30 kg/m2)46.
In the second group, there are three demographic indicators: region, education and occupation. Region was 
a three-category classification that is highly correlated with economic development: east — Liaoning, Jiangsu, 
and Shandong; middle — Heilongjiang, Henan, Hubei, and Hunan; and west — Guangxi and Guizhou. The cat-
egories of educational attainment included 0–6 years (primary school or less), 6–12 years (middle school to high 
school or the equivalent) and ≥13 years (completed a university or other tertiary education). The occupations 
were classified into three categories: unemployed, white collar (professional, government), light physical labour 
(skilled worker, service and merchant) and hard physical labour (farmer, factory worker, manufacturing worker 
and transportation worker).
The third group collected data regarding alcohol consumption behaviour. The frequency of drinking beer or 
other alcoholic beverages was used to evaluate the drinking status. Participants who answered “almost every day 
and 3–4 times a week” were coded as a frequent drinker; “once or twice a week” was included as less-frequent 
drinker; and “once or twice a month” was regarded as barely drinking; “no more than once a month and never 
drink” was coded as non-drinker.
Statistical analysis. Descriptive statistics and F tests were applied to different subgroups (Table 1). In 
longitudinal data analysis, mixed-effects models can impose time independent effects for each entity that are 
possibly correlated with the dependent variables, so we can use it to remove the unobserved time-invariant 
heterogeneity47. Thus, treating CCS and LCS as risk factors (10/day as the unit used in analyses), CCS 
and LCS odds ratios (OR) and 95% confidence intervals (CI) were calculated separately for risks of incident 
of the three types of disease. Tables 2–4 are based on a mixed effects logistic regression model for longitudi-
nal binary response data, and the statistical significance was 2-sided and denoted at p < 0.0548. All analyses 
were conducted in three different age groups (18–35, 36–55 and 56–80 years) and were analysed using R 
version 3.3.2.
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